The Effect of Methylphenidate on The Consciousness Level of Intoxicated Patients; a Double-Blind Clinical Trial
Archives of Academic Emergency Medicine,
Vol. 13 No. 1 (2025),
6 September 2025
,
Page e55
https://doi.org/10.22037/aaemj.v13i1.2721
Abstract
Introduction: Intoxication-related unconsciousness is a frequent and challenging condition in emergency medicine, where rapid interventions are critical to improve patient outcomes. This study aimed to evaluate the efficacy of methylphenidate in improving consciousness levels of intoxicated patients.
Methods: In this double-blind clinical trial, intoxicated patients over 18 years of age with the Glasgow Coma Score (GCS) 13 and below were studied. 51 people were included in the intervention group and received methylphenidate, while 50 were in the control group and received placebo. Consciousness levels were measured using the Reed score before and at 12, 24, 36, and 48 hours post-intervention and compared between groups using SPSS software version 21.
Results: 101 patients with the mean age of 34± 14.26 (range: 17-81) years were studied (55.4% male). 74.5% of the people in the intervention group achieved the most alert state (a REED score of zero) after 48 hours, compared to only 32% in the control group. The intervention group had significantly lower average Reed scale (0.33) compared to the control group (0.76) 48 hours after the treatment (p = 0.001). Using Methylphenidate in treatment of intoxicated patients showed effect size of 0.703 (95% confidence interval (CI): 0.299-1.104), number needed to treat of 2.17 (95%CI: 1.48 - 3.34), absolute risk reduction of 46% (95%CI: 0.29 -0.67), and relative risk reduction of 57% (95%CI: 0.37 - 0.72).
Conclusion: It seems that, the use of methylphenidate in patients with intoxication can reduce the time it takes for their consciousness to return to a normal level. Since benzodiazepines are the leading cause of poisoning, this study suggests that methylphenidate could be beneficial in cases of benzodiazepine poisoning to aid in cognitive recovery.
- Consciousness
- Methylphenidate
- Mental Status Schedule
- Poisoning
How to Cite
References
Nagashima K, Sumida M, Imanaka S, Kuwabara T, Kaneko I, Miyake Y, et al. Evaluation of factors related to overdose in patients with impaired consciousness who are transported by emergency medical services: an age-specific research. Journal of pharmaceutical health care and sciences. 2021;7:1-7.
Mohammed E, Gawesh E-S. Acute poisoning induced coma: characteristics and predictive role of early creatine phosphokinase on its outcome. Ain Shams Journal of Forensic Medicine and Clinical Toxicology. 2019;32(1):1-9.
De Paepe P, Lemoyne S, Buylaert W. Disorders of consciousness induced by intoxication. Neurologic clinics. 2012;30(1):359-84.
Traub SJ, Wijdicks EF. Initial diagnosis and management of coma. Emergency Medicine Clinics. 2016;34(4):777-93.
Thompson TM, Theobald J, Lu J, Erickson TB. The general approach to the poisoned patient. Disease-a-Month. 2014;60(11):509-24.
Shellenberg TP, Stoops WW, Lile JA, Rush CR. An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Review of Clinical Pharmacology. 2020;13(8):825-33.
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proceedings of the national academy of sciences. 2001;98(2):676-82.
Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006;129(3):564-83.
Kim YW, Shin J-C, An Y-s. Effects of methylphenidate on cerebral glucose metabolism in patients with impaired consciousness after acquired brain injury. Clinical neuropharmacology. 2009;32(6):335-9.
Docherty JR, Alsufyani HA. Pharmacology of drugs used as stimulants. The Journal of Clinical Pharmacology. 2021;61:S53-S69.
Shier AC, Reichenbacher T, Ghuman HS, Ghuman JK. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. Journal of central nervous system disease. 2013;5:JCNSD. S6691.
Kamali A, Mahmodiyeh B, Jamalian SM, Kishani A, Dalvandi M. The effect of methylphenidate on the level of consciousness and weaning from the ventilator in patients with brain injury in the intensive care unit. Anaesthesia, Pain & Intensive Care. 2021;25(5):643–6.
Jin C, Schachar R. Methylphenidate treatment of attention-defit/hyperactivity disorder secondary to traumatic brain injury: A critical appraisal of treatment studies. CNS spectrums. 2004;9(3):217-26.
Huang C-H, Huang C-C, Sun C-K, Lin G-H, Hou W-H. Methylphenidate on cognitive improvement in patients with traumatic brain injury: a meta-analysis. Current neuropharmacology. 2016;14(3):272-81.
Zhang W-T, Wang Y-F. Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury. Medicine. 2017;96(25):e6960.
Latifi-Pour M, Hassanian-Moghaddam H, Mortazavi H-S, Shadnia S, Zamani N, Rahimi M. The Effect of methylphenidate on reed scaling in benzodiazepine poisoning: A prospective trial. Current Clinical Pharmacology. 2020;15(1):81-8.
Speech TJ, Rao SM, Osmon DC, Sperry LT. A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Injury. 1993;7(4):333-8.
Tabibzadeh SA, Yazdani R, Zare S, Golmirzaei J, Solati SM, Tehrani BT. Epidemiologic study of poisonings in patients reffering to emergency ward of Shahid Mohammadi university hospital in Bandar Abbas. Hormozgan Medical Journal. 2021;18(4):313-22.
Kazemifar AM, Mirakbari SM, Yazdi Z, Bitazar B, Soleimani P. Clinicoepidemiologic profile of patients with poisoning presenting to a tertiary care hospital; a one year preliminary descriptive study. Journal of Preventive Epidemiology. 2020;5(1):e15.
Moore PW, Donovan JW, Burkhart KK, Waskin JA, Hieger MA, Adkins AR, et al. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. Journal of Medical Toxicology. 2014;10:126-32.
Hassanian-Moghaddam H, Zamani N, Rahimi M, Shadnia S, Pajoumand A, Sarjami S. Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011. Archives of Iranian medicine. 2014;17(8).
Ahmadi A, Pakravan N, Ghazizadeh Z. Pattern of acute food, drug, and chemical poisoning in Sari City, Northern Iran. Human & experimental toxicology. 2010;29(9):731-8.
Mehrpour O, Akbari A, Jahani F, Amirabadizadeh A, Allahyari E, Mansouri B, et al. Epidemiological and clinical profiles of acute poisoning in patients admitted to the intensive care unit in eastern Iran (2010 to 2017). BMC emergency medicine. 2018;18:1-9.
Ala A, Shams Vahdati S, Moosavi L, Sadeghi H. Studying the relationship between age, gender and other demographic factors with the type of agent used for self-poisoning at a poisoning referral center in North West Iran. 2011.
Akhlaghi M, Arbabi Z, Khadivi R. Pattern of acute poisoning in Shahrekord (Western Iran). 2009.
Khodabandeh F, Emamhadi M, Mostafazadeh B. Epidemiological assessment of acute poisoning death–one year survey. International Journal of Medical Toxicology and Forensic Medicine. 2012;2(3 (Summer)):103-9.
Reynolds JC, Rittenberger JC, Callaway CW. Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest. Resuscitation. 2013;84(6):818-24.
- Abstract Viewed: 246 times
- pdf Downloaded: 843 times
Download Statastics
Make a Submission
SJR
COPE
